• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹部开放处理中抗生素停用后暴发性细菌性腹膜炎复发的预测因素

Predictors of recurrence of fulminant bacterial peritonitis after discontinuation of antibiotics in open management of the abdomen.

作者信息

Visser M R, Bosscha K, Olsman J, Vos A, Hulstaert P F, van Vroonhoven T J, van der Werken C

机构信息

Department of Clinical Microbiology, University Hospital Utrecht, The Netherlands.

出版信息

Eur J Surg. 1998 Nov;164(11):825-9. doi: 10.1080/110241598750005228.

DOI:10.1080/110241598750005228
PMID:9845127
Abstract

OBJECTIVE

To assess a scoring system for predicting recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial treatment in patients being treated by open management of the abdomen for persistent bacterial peritonitis after perforation of the digestive tract, anastomotic disruption, or necrotising pancreatitis.

DESIGN

Retrospective study.

SETTING

University Hospital, The Netherlands.

SUBJECTS

58 consecutive patients.

MAIN OUTCOME MEASUREMENTS

Recurrence of fulminant bacterial peritonitis and survival.

RESULTS

13 of the 58 patients (22%) died during the initial course of antimicrobial drugs. 14 of the remaining 45 patients had a recurrence of fulminant bacterial peritonitis after discontinuation of antimicrobial drugs, 4 of whom died. Predictive criteria included raised white cell count (WCC) (p = 0.02), duration of initial antibiotic treatment (p = 0.05), and deterioration in Simplified Acute Physiology Score (p = 0.05). Using the WCC and the duration of initial antimicrobial treatment together with other variables that showed a predictive trend (body temperature, percentage band cells, underlying disease, and use of inotropic agents), in a new scoring system (0-12), fulminant bacterial peritonitis did not recur when the score was 0-3, but in 9 of 11 patients with a score of 6 or more it did (p < 0.001).

CONCLUSION

Patients at increased risk of recurrence of fulminant bacterial peritonitis during open management of the abdomen can be identified at the time of discontinuation of antimicrobial treatment by a new scoring system; antimicrobial treatment should not be discontinued in patients with a score of 6 or more.

摘要

目的

评估一种评分系统,用于预测在因消化道穿孔、吻合口破裂或坏死性胰腺炎导致持续性细菌性腹膜炎而接受腹部开放治疗的患者中,抗菌治疗停止后暴发性细菌性腹膜炎的复发情况。

设计

回顾性研究。

地点

荷兰大学医院。

研究对象

58例连续患者。

主要观察指标

暴发性细菌性腹膜炎的复发和生存情况。

结果

58例患者中有13例(22%)在初始抗菌药物治疗过程中死亡。其余45例患者中有14例在抗菌药物停用后出现暴发性细菌性腹膜炎复发,其中4例死亡。预测标准包括白细胞计数(WCC)升高(p = 0.02)、初始抗生素治疗持续时间(p = 0.05)以及简化急性生理学评分恶化(p = 0.05)。在一个新的评分系统(0 - 12分)中,将WCC、初始抗菌治疗持续时间与其他显示出预测趋势的变量(体温、杆状核细胞百分比、基础疾病和使用的血管活性药物)结合起来,当评分在0 - 3分时,暴发性细菌性腹膜炎未复发,但在11例评分6分及以上的患者中有9例复发(p < 0.001)。

结论

通过一种新的评分系统,在腹部开放治疗期间暴发性细菌性腹膜炎复发风险增加的患者,在抗菌治疗停止时可以被识别出来;评分6分及以上的患者不应停止抗菌治疗。

相似文献

1
Predictors of recurrence of fulminant bacterial peritonitis after discontinuation of antibiotics in open management of the abdomen.腹部开放处理中抗生素停用后暴发性细菌性腹膜炎复发的预测因素
Eur J Surg. 1998 Nov;164(11):825-9. doi: 10.1080/110241598750005228.
2
Open management of the abdomen and planned reoperations in severe bacterial peritonitis.重症细菌性腹膜炎的腹部开放管理及计划性再次手术
Eur J Surg. 2000 Jan;166(1):44-9. doi: 10.1080/110241500750009690.
3
Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.呼吸机相关性肺炎患者感染复发和死亡的早期预测因素
Crit Care Med. 2007 Jan;35(1):146-54. doi: 10.1097/01.CCM.0000249826.81273.E4.
4
Evaluation of prosthetic mesh closure in semiopen-abdomen patients.半开放腹腔患者人工补片闭合术的评估
Hernia. 2002 Sep;6(3):124-9. doi: 10.1007/s10029-002-0072-2. Epub 2002 Jul 23.
5
Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.肝硬化患者自发性细菌性腹膜炎:头孢噻肟治疗患者感染缓解及生存的预测因素
Hepatology. 1993 Feb;17(2):251-7.
6
Recurrent and relapsing peritonitis: causative organisms and response to treatment.复发性和再发性腹膜炎:致病微生物及对治疗的反应
Am J Kidney Dis. 2009 Oct;54(4):702-10. doi: 10.1053/j.ajkd.2009.04.032. Epub 2009 Jul 4.
7
Complications of planned relaparotomy in patients with severe general peritonitis.重症弥漫性腹膜炎患者计划性再次剖腹手术的并发症
Eur J Surg. 1997 Jan;163(1):61-6.
8
Predictors of outcome in patients with postoperative intra-abdominal infection.术后腹腔内感染患者预后的预测因素
Eur J Surg. 1996 Aug;162(8):619-25.
9
Intraperitoneal micro-organisms and the severity of peritonitis.腹腔内微生物与腹膜炎的严重程度
Eur J Surg. 1995 Jul;161(7):501-8.
10
[Diagnosis and therapy of 186 spontaneous bacterial peritonitis patients with end-stage liver disease].[186例终末期肝病自发性细菌性腹膜炎患者的诊断与治疗]
Zhonghua Gan Zang Bing Za Zhi. 2004 Jun;12(6):350-2.

引用本文的文献

1
Korean Guidelines for Use of Antibiotics for Intra-abdominal Infections in Adults.《韩国成人腹腔内感染抗生素使用指南》
Infect Chemother. 2022 Dec;54(4):812-853. doi: 10.3947/ic.2022.0156.
2
Is fixed short-course antimicrobial therapy justified for patients who are critically ill with intra-abdominal infections?对于患有腹腔内感染的重症患者,固定疗程的短程抗菌治疗是否合理?
J Anus Rectum Colon. 2019 Apr 25;3(2):53-59. doi: 10.23922/jarc.2019-001. eCollection 2019.
3
Management of peritonitis in the critically ill patient.危重症患者腹膜炎的管理
Surg Clin North Am. 2006 Dec;86(6):1323-49. doi: 10.1016/j.suc.2006.09.006.